Clinical trial

A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders

NCT07579741

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-05-26

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-05-26Date precision: day

Registry last updated2026-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

JL18008 20 μg/kgDRUG

Placebo (for 20 μg/kg Group)DRUG

JL18008 40 μg/kgDRUG

Placebo (for 40 μg/kg Group)DRUG

JL18008 70 μg/kgDRUG

Placebo (for 70 μg/kg Group)DRUG

Sponsors & collaborators

Jecho Biopharmaceuticals Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07579741 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.